Glenmark Pharmaceuticals informs about ESG rating

05 Jan 2026 Evaluate

Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015 read with SEBI Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, Glenmark Pharmaceuticals has informed that SES ESG Research vide its email dated January 04, 2026, has assigned an ESG rating of ‘71.1’ for F.Y. 2025. The company has clarified that the Company has not engaged SES ESG for ESG Rating. SES ESG has independently assigned the rating based on publicly available information for F.Y. 2025.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2010.00 1.00 (0.05%)
14-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1191.95
Cipla 1434.60
Zydus Lifesciences 884.50
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×